LOTTE BIOLOGICS will be participating in World ADC Asia 2025, taking place from June 10–12 in Incheon, South Korea!

As a company committed to advancing antibody-drug conjugate (ADC) innovation, we’re proud to be part of Asia’s leading ADC-focused conference. Join us to learn more about our cutting-edge ADC manufacturing capabilities, including our state-of-the-art Syracuse ADC facility and our patented SoluFlex Link™ platform.
We look forward to connecting with global ADC leaders and forging impactful collaborations to drive the future of targeted therapies.

See you in Incheon!

hashtag#LOTTEBIOLOGICS hashtag#WorldADCAsia hashtag#ADC hashtag#Biotech hashtag#CDMO hashtag#SoluFlexLink hashtag#Biomanufacturing hashtag#NextGenTherapies